<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39425170</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Trials</Title><ISOAbbreviation>Trials</ISOAbbreviation></Journal><ArticleTitle>Implementation of a tailored multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for urinary tract infections in frail older adults (ImpresU) in four European countries: a process evaluation alongside a pragmatic cluster randomized controlled trial.</ArticleTitle><Pagination><StartPage>691</StartPage><MedlinePgn>691</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">691</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-024-08545-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We previously performed a pragmatic cluster randomized controlled trial (RCT) in general practices and older adult care organizations in Poland, the Netherlands, Norway, and Sweden. We found that a multifaceted antibiotic stewardship intervention (ASI) substantially reduced antibiotic use for suspected urinary tract infections (UTIs) in frail older adults compared with usual care. We aimed to evaluate the implementation process of the ASI to provide recommendations for clinical practice.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a process evaluation alongside the cluster RCT. The ASI consisted of a decision-tool and a toolbox, which were implemented using a participatory-action-research (PAR) approach with sessions for education and evaluation. We documented the implementation process of the intervention and administered a questionnaire to health care professionals (HCPs) from participating organizations in the intervention and usual care clusters. We evaluated the multiple components of the intervention and its implementation following a structured framework.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The questionnaire was completed by 254 HCPs from the 38 participating clusters. All components were largely delivered according to plan and evaluated as useful. The decision-tool and toolbox materials were reported to facilitate decision-making on UTIs. Regarding the PAR approach, educational sessions focusing on the distinction between UTIs and asymptomatic bacteriuria were held in all 19 intervention clusters. In 17 out of these 19 clusters, evaluation sessions took place, which were reported to help remind HCPs to implement the ASI. During both sessions, HCPs valued the reflection that took place and the resulting awareness of their behavior. It allowed them to explore implementation barriers and to tailor their local implementation process to overcome these. For example, HCPs organized extra educational sessions or revised local policies to incorporate the use of the decision-tool. Various HCPs took key roles in implementation. Staff changes and the COVID-19 pandemic were important contextual barriers.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We found each component of the multifaceted ASI and its implementation to have added value in the process to improve antibiotic prescribing for suspected UTIs in a heterogeneous older adult care setting. We recommend using a multifaceted, multidisciplinary approach that enables HCPs to reflect on their current practice and accordingly tailor local implementation.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT03970356. Registered on May 31, 2019.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hartman</LastName><ForeName>Esther A R</ForeName><Initials>EAR</Initials><Identifier Source="ORCID">0000-0003-0907-2476</Identifier><AffiliationInfo><Affiliation>Department of Medicine for Older People, Amsterdam, UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands. e.hartman1@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aging &amp; Later Life, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands. e.hartman1@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, Utrecht, 3584 CG, The Netherlands. e.hartman1@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groen</LastName><ForeName>Wim G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Department of Medicine for Older People, Amsterdam, UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aging &amp; Later Life, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heltveit-Olsen</LastName><ForeName>Silje Rebekka</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0000-0002-8645-5836</Identifier><AffiliationInfo><Affiliation>The Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Blindern, Oslo, P.O. Box 1130, 0318, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindbæk</LastName><ForeName>Morten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Blindern, Oslo, P.O. Box 1130, 0318, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Høye</LastName><ForeName>Sigurd</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Blindern, Oslo, P.O. Box 1130, 0318, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lithén</LastName><ForeName>Sara Sofia</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>The Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Blindern, Oslo, P.O. Box 1130, 0318, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sundvall</LastName><ForeName>Pär-Daniel</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Box 454, 405 30, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research, Education, Development &amp; Innovation, Primary Health Care, Region Västra Götaland, FoUUI-Centrum Södra Älvsborg, Sven Eriksonsplatsen 4, SE-503 38, Borås, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sundvall</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research, Education, Development &amp; Innovation, Primary Health Care, Region Västra Götaland, FoUUI-Centrum Södra Älvsborg, Sven Eriksonsplatsen 4, SE-503 38, Borås, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snaebjörnsson Arnljots</LastName><ForeName>Egill</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Box 454, 405 30, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research, Education, Development &amp; Innovation, Primary Health Care, Region Västra Götaland, FoUUI-Centrum Södra Älvsborg, Sven Eriksonsplatsen 4, SE-503 38, Borås, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunnarsson</LastName><ForeName>Ronny</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Box 454, 405 30, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research, Education, Development &amp; Innovation, Primary Health Care, Region Västra Götaland, FoUUI-Centrum Södra Älvsborg, Sven Eriksonsplatsen 4, SE-503 38, Borås, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowalczyk</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Family and Community Medicine, The Faculty of Health Sciences, The Medical University of Lodz, Lodz, 90-419, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godycki-Cwirko</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Family and Community Medicine, The Faculty of Health Sciences, The Medical University of Lodz, Lodz, 90-419, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Pol</LastName><ForeName>Alma C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, Utrecht, 3584 CG, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Platteel</LastName><ForeName>Tamara N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, Utrecht, 3584 CG, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monnier</LastName><ForeName>Annelie A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-5844-286X</Identifier><AffiliationInfo><Affiliation>Department of Medicine for Older People, Amsterdam, UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aging &amp; Later Life, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verheij</LastName><ForeName>Theo J M</ForeName><Initials>TJM</Initials><AffiliationInfo><Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, Utrecht, 3584 CG, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hertogh</LastName><ForeName>Cees M P M</ForeName><Initials>CMPM</Initials><AffiliationInfo><Affiliation>Department of Medicine for Older People, Amsterdam, UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aging &amp; Later Life, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03970356</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D065007">Pragmatic Clinical Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trials</MedlineTA><NlmUniqueID>101263253</NlmUniqueID><ISSNLinking>1745-6215</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014552" MajorTopicYN="Y">Urinary Tract Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073602" MajorTopicYN="Y">Antimicrobial Stewardship</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016330" MajorTopicYN="Y">Frail Elderly</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="Y">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibiotic stewardship</Keyword><Keyword MajorTopicYN="N">Older adults</Keyword><Keyword MajorTopicYN="N">Process evaluation</Keyword><Keyword MajorTopicYN="N">Urinary tract infections</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>23</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39425170</ArticleId><ArticleId IdType="pmc">PMC11488242</ArticleId><ArticleId IdType="doi">10.1186/s13063-024-08545-4</ArticleId><ArticleId IdType="pii">10.1186/s13063-024-08545-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Buul LW, Veenhuizen RB, Achterberg WP, Schellevis FG, Essink RT, de Greeff SC, et al. Antibiotic prescribing in Dutch nursing homes: how appropriate is it? J Am Med Dir Assoc. 2015;16(3):229–37.</Citation><ArticleIdList><ArticleId IdType="pubmed">25458444</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf MS, Gaur S, Bushen OY, Chopra T, Chung P, Clifford K, et al. Diagnosis, treatment, and prevention of urinary tract infections in post-acute and long-term care settings: a consensus statement from AMDA’s infection advisory subcommittee. J Am Med Dir Assoc. 2020;21(1):12–24 e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">31888862</ArticleId></ArticleIdList></Reference><Reference><Citation>van Buul LW, Vreeken HL, Bradley SF, Crnich CJ, Drinka PJ, Geerlings SE, et al. The development of a decision tool for the empiric treatment of suspected urinary tract infection in frail older adults: a Delphi consensus procedure. J Am Med Dir Assoc. 2018;19(9):757–64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8048094</ArticleId><ArticleId IdType="pubmed">29910137</ArticleId></ArticleIdList></Reference><Reference><Citation>Läkemedelsbehandling av urinvägsinfektioner i öppenvård - behandlingsrekommendation. Swedish guideline. Uppsala: Läkemedelsverket; 2017. https://lakemedelsverket.se/uvi.</Citation></Reference><Reference><Citation>Richtlijn Urineweginfecties bij kwetsbare ouderen. Dutch guideline. Utrecht: Verenso; 2018. https://www.verenso.nl/kwaliteit/richtlijnen-en-praktijkvoering/richtlijnendatabase/urineweginfecties.</Citation></Reference><Reference><Citation>Agarwal M, Estrada LV, Gracner T, Dick AW, Stone PW. Nursing home antibiotic stewardship policy and antibiotics use: 2013–2017. J Am Med Dir Assoc. 2022;23(3):482–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8776896</ArticleId><ArticleId IdType="pubmed">34297980</ArticleId></ArticleIdList></Reference><Reference><Citation>Akselsen PEO, S. Urinveisinfeksjoner i sykehjem, versjon 2.2. Norwegian guideline. 2020.</Citation></Reference><Reference><Citation>Nicolle LE, Gupta K, Bradley SF, Colgan R, DeMuri GP, Drekonja D, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68(10):1611–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">31506700</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming A, Bradley C, Cullinan S, Byrne S. Antibiotic prescribing in long-term care facilities: a qualitative, multidisciplinary investigation. BMJ Open. 2014;4(11): e006442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4225237</ArticleId><ArticleId IdType="pubmed">25377014</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartman EAR, Groen WG, Heltveit-Olsen SR, Lindbaek M, Hoye S, Sundvall PD, et al. Multifaceted antibiotic stewardship intervention using a participatory-action-research approach to improve antibiotic prescribing for urinary tract infections in frail elderly (ImpresU): study protocol for a European qualitative study followed by a pragmatic cluster randomised controlled trial. BMJ Open. 2021;11(10): e052552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8499316</ArticleId><ArticleId IdType="pubmed">34620666</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartman EAR, Groen WG, Heltveit-Olsen SR, Lindbaek M, Hoye S, Sundvall PD, et al. Decisions on antibiotic prescribing for suspected urinary tract infections in frail older adults: a qualitative study in four European countries. Age Ageing. 2022;51(6):afac134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9191618</ArticleId><ArticleId IdType="pubmed">35697352</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartman EAR, van de Pol AC, Heltveit-Olsen SR, Lindbaek M, Hoye S, Lithen SS, et al. Effect of a multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for suspected urinary tract infections in frail older adults (ImpresU): pragmatic cluster randomised controlled trial in four European countries. BMJ. 2023;380: e072319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9943914</ArticleId><ArticleId IdType="pubmed">36813284</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone M, Paul M, Yahav D, Orlando G, Tiseo G, Prendki V, et al. Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities. Clin Microbiol Infect. 2019;25(5):562–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30076978</ArticleId></ArticleIdList></Reference><Reference><Citation>Faber MJ, Burgers JS, Westert GP. A sustainable primary care system: lessons from the Netherlands. J Ambul Care Manage. 2012;35(3):174–81.</Citation><ArticleIdList><ArticleId IdType="pubmed">22668606</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders RP, Evans MH, Joshi P. Developing a process-evaluation plan for assessing health promotion program implementation: a how-to guide. Health Promot Pract. 2005;6(2):134–47.</Citation><ArticleIdList><ArticleId IdType="pubmed">15855283</ArticleId></ArticleIdList></Reference><Reference><Citation>French C, Pinnock H, Forbes G, Skene I, Taylor SJC. Process evaluation within pragmatic randomised controlled trials: what is it, why is it done, and can we find it?-a systematic review. Trials. 2020;21(1):916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7650157</ArticleId><ArticleId IdType="pubmed">33168067</ArticleId></ArticleIdList></Reference><Reference><Citation>May CR, Cummings A, Girling M, Bracher M, Mair FS, May CM, et al. Using normalization process theory in feasibility studies and process evaluations of complex healthcare interventions: a systematic review. Implement Sci. 2018;13(1):80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5992634</ArticleId><ArticleId IdType="pubmed">29879986</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350: h1258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4366184</ArticleId><ArticleId IdType="pubmed">25791983</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnan LS, A. Process evaluations for public health interventions and research. San Francisco, United States: Jossey Bass; 2002.</Citation></Reference><Reference><Citation>Appelhof B, Bakker C, van Duinen-van den IJCL, Zwijsen SA, Smalbrugge M, Verhey FRJ, et al. Process evaluation of an intervention for the management of neuropsychiatric symptoms in young-onset dementia. J Am Med Dir Assoc. 2018;19(8):663-71.</Citation><ArticleIdList><ArticleId IdType="pubmed">29653809</ArticleId></ArticleIdList></Reference><Reference><Citation>Peryer G, Kelly S, Blake J, Burton JK, Irvine L, Cowan A, et al. Contextual factors influencing complex intervention research processes in care homes: a systematic review and framework synthesis. Age Ageing. 2022;51(3):afac014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8887840</ArticleId><ArticleId IdType="pubmed">35231097</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwijsen SA, Smalbrugge M, Eefsting JA, Gerritsen DL, Hertogh CM, Pot AM. Grip on challenging behavior: process evaluation of the implementation of a care program. Trials. 2014;15: 302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4132912</ArticleId><ArticleId IdType="pubmed">25059544</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter R, Campbell A, Ellard DR, Shaw C, Gardner E, Agus A, et al. Multifaceted intervention to reduce antimicrobial prescribing in care homes: a process evaluation of a UK-based non-randomised feasibility study. BMJ Open. 2019;9(11): e032185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6887004</ArticleId><ArticleId IdType="pubmed">31753887</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulscher M, Prins JM. Antibiotic stewardship: does it work in hospital practice? A review of the evidence base. Clin Microbiol Infect. 2017;23(11):799–805.</Citation><ArticleIdList><ArticleId IdType="pubmed">28750920</ArticleId></ArticleIdList></Reference><Reference><Citation>Rzewuska M, Charani E, Clarkson JE, Davey PG, Duncan EM, Francis JJ, et al. Prioritizing research areas for antibiotic stewardship programmes in hospitals: a behavioural perspective consensus paper. Clin Microbiol Infect. 2019;25(2):163–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30195471</ArticleId></ArticleIdList></Reference><Reference><Citation>Molstad S, Lofmark S, Carlin K, Erntell M, Aspevall O, Blad L, et al. Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance. Bull World Health Organ. 2017;95(11):764–73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5677604</ArticleId><ArticleId IdType="pubmed">29147057</ArticleId></ArticleIdList></Reference><Reference><Citation>The Swedish strategic programme against antibiotic resistance [Available from: https://strama.se/contact/?lang=en.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5677604</ArticleId><ArticleId IdType="pubmed">29147057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ten Oever J, Harmsen M, Schouten J, Ouwens M, van der Linden PD, Verduin CM, et al. Human resources required for antimicrobial stewardship teams: a Dutch consensus report. Clin Microbiol Infect. 2018;24(12):1273–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30036665</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>